glp-1 agonists australia Updated guidance for patients using GLP-1/GIP receptor Targeting GLP-1, GIP & GCG

Reduced gastrointestinal motility and altered drug absorption may require dose adjustments of medications including warfarin, direct oral anticoagulants, opioids, and antiepileptic agents

His primary care provider said P.B

The beneficial actions based on activation of the entero-insular axis are complex and multitargeted, involving the gut, brain, pancreas, and liver

I wont again review here the issues of exorbitant costs, reimbursement coverage by insurers, health inequities, and lack of availability, since these were previously summarized

doi: 10.1038/nature22394 44 FinanBMaTOttawayNMllerTDHabeggerKMHeppnerKMet al